Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Surface microstructures on planar substrates and textile fibers guide neurite outgrowth: a scaffold solution to push limits of critical nerve defect regeneration?

Weigel S, Osterwalder T, Tobler U, Yao L, Wiesli M, Lehnert T, Pandit A, Bruinink A.

PLoS One. 2012;7(12):e50714. doi: 10.1371/journal.pone.0050714. Epub 2012 Dec 12.

2.

Spatial and temporal control of gene expression in Drosophila using the inducible GeneSwitch GAL4 system. I. Screen for larval nervous system drivers.

Nicholson L, Singh GK, Osterwalder T, Roman GW, Davis RL, Keshishian H.

Genetics. 2008 Jan;178(1):215-34. doi: 10.1534/genetics.107.081968.

3.

Numb proteins specify asymmetric cell fates via an endocytosis- and proteasome-independent pathway.

Tang H, Rompani SB, Atkins JB, Zhou Y, Osterwalder T, Zhong W.

Mol Cell Biol. 2005 Apr;25(8):2899-909.

4.

Drosophila serpin 4 functions as a neuroserpin-like inhibitor of subtilisin-like proprotein convertases.

Osterwalder T, Kuhnen A, Leiserson WM, Kim YS, Keshishian H.

J Neurosci. 2004 Jun 16;24(24):5482-91.

5.

Neuroserpin, a neuroprotective factor in focal ischemic stroke.

Cinelli P, Madani R, Tsuzuki N, Vallet P, Arras M, Zhao CN, Osterwalder T, Rülicke T, Sonderegger P.

Mol Cell Neurosci. 2001 Nov;18(5):443-57.

PMID:
11922137
6.

Molecular genetic approaches to the targeted suppression of neuronal activity.

White B, Osterwalder T, Keshishian H.

Curr Biol. 2001 Dec 11;11(24):R1041-53. Review.

7.

A conditional tissue-specific transgene expression system using inducible GAL4.

Osterwalder T, Yoon KS, White BH, Keshishian H.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12596-601.

8.

Targeted attenuation of electrical activity in Drosophila using a genetically modified K(+) channel.

White BH, Osterwalder TP, Yoon KS, Joiner WJ, Whim MD, Kaczmarek LK, Keshishian H.

Neuron. 2001 Sep 13;31(5):699-711.

9.

The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin.

Osterwalder T, Cinelli P, Baici A, Pennella A, Krueger SR, Schrimpf SP, Meins M, Sonderegger P.

J Biol Chem. 1998 Jan 23;273(4):2312-21.

10.

Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse.

Krueger SR, Ghisu GP, Cinelli P, Gschwend TP, Osterwalder T, Wolfer DP, Sonderegger P.

J Neurosci. 1997 Dec 1;17(23):8984-96.

11.

Human neuroserpin (PI12): cDNA cloning and chromosomal localization to 3q26.

Schrimpf SP, Bleiker AJ, Brecevic L, Kozlov SV, Berger P, Osterwalder T, Krueger SR, Schinzel A, Sonderegger P.

Genomics. 1997 Feb 15;40(1):55-62.

PMID:
9070919
12.

Neuroserpin, an axonally secreted serine protease inhibitor.

Osterwalder T, Contartese J, Stoeckli ET, Kuhn TB, Sonderegger P.

EMBO J. 1996 Jun 17;15(12):2944-53.

13.

Cell-cell adhesion by homophilic interaction of the neuronal recognition molecule axonin-1.

Rader C, Stoeckli ET, Ziegler U, Osterwalder T, Kunz B, Sonderegger P.

Eur J Biochem. 1993 Jul 1;215(1):133-41.

14.

The axonally secreted cell adhesion molecule, axonin-1. Primary structure, immunoglobulin-like and fibronectin-type-III-like domains and glycosyl-phosphatidylinositol anchorage.

Zuellig RA, Rader C, Schroeder A, Kalousek MB, Von Bohlen und Halbach F, Osterwalder T, Inan C, Stoeckli ET, Affolter HU, Fritz A, et al.

Eur J Biochem. 1992 Mar 1;204(2):453-63.

Supplemental Content

Loading ...
Support Center